Anna Metafa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anna Metafa has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Abdul Kasem
Department of Surgery, Princess Royal University Hospital, King’s College Hospital NHS Foundation Trust, Orpington, UK
1 shared publication- Ali Sever
Guy's and St Thomas’ Hospitals NHS Trust, London, UK
1 shared publication - Champika Jayathilake
Department of Radiology, Princess Royal University Hospital, King’s College Hospital NHS Foundation Trust, Orpington, UK
1 shared publication Charlottefreya Longman
1 shared publication- Cristina Alfaro Vergara
Department of Medical Technology, Facultad de Ciencias de la Salud, Universidad de Tarapacá, Arica 1000000, Chile
1 shared publication Dimitris Kitsos
Department of Radiology, Princess Royal University Hospital, King’s College Hospital NHS Foundation Trust, Orpington, UK
1 shared publication
Latest Publications
- Open Access
Dynamic AI-assisted Ipsilateral Tissue Matching for Digital Breast Tomosynthesis
Structured Purpose: To compare Digital Breast Tomosynthesis (DBT) tissue matching errors with and without artificial intelligence (AI) assistance to typical screen-detected breast tumor sizes, evaluating whether AI ameliorates lesion mislocalization beyond tumor boundaries, especially for nonexpert radiologists. The technology category is deep learning. Materials and Methods: This multicenter retrospective feasibility study conducted in April 2022 – July 2023 included 12 radiologists (mean age, 42 years ± 8) interpreting 94 lesion regions of interest in 30 women. Readers performed annotations with and without AI assistance after a minimum four-week washout period. The root mean square errors (RMSE) and maximum distance errors (MDE) were measured relative to consensus references. Stratifications included radiologist expertise ( ≥ 5 vs < 5 years), lesion abnormal-ity, and AI warnings. The Wilcoxon signed-rank test was used to assess statistical significance. Results: Across all abnormal lesions, mean RMSE was 32% higher without AI (11.70 mm vs 8.88 mm , p = .049), and mean maximum distance errors were 37.5% higher (20.68 mm vs 15.08 mm , p = .036). Non-expert radiologists showed the largest benefit: for abnormal lesions without AI warnings, RMSE was 61.9% higher without AI (12.20 mm vs 7.57 mm , p = .010) and maximum distance error was 67.5% higher (15.76 mm vs 9.47 mm , p = .028). These reductions are clinically relevant given typical screen-detected breast tumor sizes (median, 13 mm [IQR: 9–20]). Conclusion: AI-assisted tissue matching significantly reduced DBT localization errors, particularly for non-experts handling challenging cases. By keeping errors below typical tumor dimensions, AI may improve diagnostic precision and reduce risks of missed or mischaracterized lesions. Summary Statement: Dynamic artificial intelligence assisted tissue matching in digital breast tomosynthesis improves localization accuracy for non-expert radiologists, with errors in abnormal cases significantly larger (67.5%, p ≤ 0.05) without assistance. Key Points: In this multicenter retrospective study of 94 Regions of Interest (ROI) analyzed by 12 radiologists across 5 hospitals, manual tissue matching was found to have errors 32% higher in abnormal cases than AI-assisted tissue matching ( p < 0.05). For non-expert radiologists interpreting abnormal cases (excluding cases with AI warnings) without AI assistance, the root mean squared distance errors (RMSE) were found to be 61.9% higher (12.20 mm vs 7.57 mm , p < 0.01) and the maximum distance errors (MDE) was 67.6% higher (15.76 mm vs 9.47 mm , p < 0.05) than when using AI assistance. For challenging cases, many non-expert readers’ MDE without AI assistance (75th percentile: 20.21 mm ) exceeded the largest tumor dimensions (75th percentile: 20 mm ), while AI-assisted errors (75th percentile: 11.94 mm , p < 0.05) remained within median tumor sizes (12 mm ), potentially preventing correlation with non-lesion tissue.
Open AccessDynamic AI-assisted Ipsilateral Tissue Matching for Digital Breast Tomosynthesis
Structured Purpose: To compare Digital Breast Tomosynthesis (DBT) tissue matching errors with and without artificial intelligence (AI) assistance to typical screen-detected breast tumor sizes, evaluating whether AI ameliorates lesion mislocalization beyond tumor boundaries, especially for nonexpert radiologists. The technology category is deep learning. Materials and Methods: This multicenter retrospective feasibility study conducted in April 2022 – July 2023 included 12 radiologists (mean age, 42 years ± 8) interpreting 94 lesion regions of interest in 30 women. Readers performed annotations with and without AI assistance after a minimum four-week washout period. The root mean square errors (RMSE) and maximum distance errors (MDE) were measured relative to consensus references. Stratifications included radiologist expertise ( ≥ 5 vs < 5 years), lesion abnormal-ity, and AI warnings. The Wilcoxon signed-rank test was used to assess statistical significance. Results: Across all abnormal lesions, mean RMSE was 32% higher without AI (11.70 mm vs 8.88 mm , p = .049), and mean maximum distance errors were 37.5% higher (20.68 mm vs 15.08 mm , p = .036). Non-expert radiologists showed the largest benefit: for abnormal lesions without AI warnings, RMSE was 61.9% higher without AI (12.20 mm vs 7.57 mm , p = .010) and maximum distance error was 67.5% higher (15.76 mm vs 9.47 mm , p = .028). These reductions are clinically relevant given typical screen-detected breast tumor sizes (median, 13 mm [IQR: 9–20]). Conclusion: AI-assisted tissue matching significantly reduced DBT localization errors, particularly for non-experts handling challenging cases. By keeping errors below typical tumor dimensions, AI may improve diagnostic precision and reduce risks of missed or mischaracterized lesions. Summary Statement: Dynamic artificial intelligence assisted tissue matching in digital breast tomosynthesis improves localization accuracy for non-expert radiologists, with errors in abnormal cases significantly larger (67.5%, p ≤ 0.05) without assistance. Key Points: In this multicenter retrospective study of 94 Regions of Interest (ROI) analyzed by 12 radiologists across 5 hospitals, manual tissue matching was found to have errors 32% higher in abnormal cases than AI-assisted tissue matching ( p < 0.05). For non-expert radiologists interpreting abnormal cases (excluding cases with AI warnings) without AI assistance, the root mean squared distance errors (RMSE) were found to be 61.9% higher (12.20 mm vs 7.57 mm , p < 0.01) and the maximum distance errors (MDE) was 67.6% higher (15.76 mm vs 9.47 mm , p < 0.05) than when using AI assistance. For challenging cases, many non-expert readers’ MDE without AI assistance (75th percentile: 20.21 mm ) exceeded the largest tumor dimensions (75th percentile: 20 mm ), while AI-assisted errors (75th percentile: 11.94 mm , p < 0.05) remained within median tumor sizes (12 mm ), potentially preventing correlation with non-lesion tissue.
- 13 March 2024
- Published by SAGE Publications in Ultrasound
- Vol. 32 (4) , 291-295
Two cases of breast pseudoaneurysm following core biopsy: A very rare complication with different treatment options
Introduction: Breast pseudoaneurysm is a rare complication following breast interventional procedures such as core biopsies and vacuum-assisted biopsies. The occurrence of pseudoaneurysm increases with the conditions of increased breast vascularity like cancer, pregnancy and lactation. Case Report: We present two cases of pseudoaneurysm formation secondary to core biopsies of the breasts. The first patient was an 82-year-old female patient who presented with breast swelling and bruising after multiple clinical core biopsies of the left breast. Our second patient was a 47-year-old lady who presented with a palpable lump following ultrasound-guided core biopsies of the left breast. Ultrasound showed hypoechoic pulsating area with evidence of internal colour flow in connection with a vessel in both cases. Imaging appearances were in keeping with a pseudoaneurysm of the breast. Discussion: Most pseudoaneurysms are secondary to interventional procedures in the breast. Common clinical presentation is a pulsatile, palpable mass at the biopsy site soon after the biopsy or later. On B mode imaging, it presents as a well-circumscribed mass of mixed echogenicity. Typical waveform in spectral Doppler and ‘yin-yang’ sign in colour Doppler is demonstrated with a turbulent internal flow. There are different treatment options to manage pseudoaneurysms of the breast. Conclusion: Pseudoaneurysm of the breast should be considered if a patient presents with a breast mass/lump close to a recent biopsy site. On clinical examination, pulsatility of the mass should raise the suspicion and definite diagnosis can be made with spectral and colour Doppler US scan.
- 13 March 2024
- Published by SAGE Publications in Ultrasound
- Vol. 32 (4) , 291-295
Two cases of breast pseudoaneurysm following core biopsy: A very rare complication with different treatment options
Introduction: Breast pseudoaneurysm is a rare complication following breast interventional procedures such as core biopsies and vacuum-assisted biopsies. The occurrence of pseudoaneurysm increases with the conditions of increased breast vascularity like cancer, pregnancy and lactation. Case Report: We present two cases of pseudoaneurysm formation secondary to core biopsies of the breasts. The first patient was an 82-year-old female patient who presented with breast swelling and bruising after multiple clinical core biopsies of the left breast. Our second patient was a 47-year-old lady who presented with a palpable lump following ultrasound-guided core biopsies of the left breast. Ultrasound showed hypoechoic pulsating area with evidence of internal colour flow in connection with a vessel in both cases. Imaging appearances were in keeping with a pseudoaneurysm of the breast. Discussion: Most pseudoaneurysms are secondary to interventional procedures in the breast. Common clinical presentation is a pulsatile, palpable mass at the biopsy site soon after the biopsy or later. On B mode imaging, it presents as a well-circumscribed mass of mixed echogenicity. Typical waveform in spectral Doppler and ‘yin-yang’ sign in colour Doppler is demonstrated with a turbulent internal flow. There are different treatment options to manage pseudoaneurysms of the breast. Conclusion: Pseudoaneurysm of the breast should be considered if a patient presents with a breast mass/lump close to a recent biopsy site. On clinical examination, pulsatility of the mass should raise the suspicion and definite diagnosis can be made with spectral and colour Doppler US scan.